Cargando…

Plasma neurofilament light is a predictor of neurological outcome 12 h after cardiac arrest

BACKGROUND: Previous studies have reported high prognostic accuracy of circulating neurofilament light (NfL) at 24–72 h after out-of-hospital cardiac arrest (OHCA), but performance at earlier time points and after in-hospital cardiac arrest (IHCA) is less investigated. We aimed to assess plasma NfL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levin, Helena, Lybeck, Anna, Frigyesi, Attila, Arctaedius, Isabelle, Thorgeirsdóttir, Bergthóra, Annborn, Martin, Moseby-Knappe, Marion, Nielsen, Niklas, Cronberg, Tobias, Ashton, Nicholas J., Zetterberg, Henrik, Blennow, Kaj, Friberg, Hans, Mattsson-Carlgren, Niklas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960417/ https://www.ncbi.nlm.nih.gov/pubmed/36829239 http://dx.doi.org/10.1186/s13054-023-04355-3

Ejemplares similares

Performance of a guideline-recommended algorithm for prognostication of poor neurological outcome after cardiac arrest
por: Moseby-Knappe, Marion, et al.
Publicado: (2020)

Association Between EEG Patterns and Serum Neurofilament Light After Cardiac Arrest: A Post Hoc Analysis of the TTM Trial
por: Grindegård, Linnéa, et al.
Publicado: (2022)

Serum markers of brain injury can predict good neurological outcome after out-of-hospital cardiac arrest
por: Moseby-Knappe, Marion, et al.
Publicado: (2021)

Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer's disease
por: Raket, Lars Lau, et al.
Publicado: (2020)

Circulating dipeptidyl peptidase 3 on intensive care unit admission is a predictor of organ dysfunction and mortality
por: Frigyesi, Attila, et al.
Publicado: (2021)

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
por: Mattsson, Niklas, et al.
Publicado: (2017)

Serum tau and neurological outcome in cardiac arrest
por: Mattsson, Niklas, et al.
Publicado: (2017)

Alzheimer Disease Blood Biomarkers in Patients With Out-of-Hospital Cardiac Arrest
por: Ashton, Nicholas J., et al.
Publicado: (2023)

Predicting neurological outcome after out-of-hospital cardiac arrest with cumulative information; development and internal validation of an artificial neural network algorithm
por: Andersson, Peder, et al.
Publicado: (2021)

Neurofilament light chain on intensive care admission is an independent predictor of mortality in COVID-19: a prospective multicenter study
por: Sievert, Theodor, et al.
Publicado: (2023)

Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial
por: Wihersaari, Lauri, et al.
Publicado: (2020)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
por: Mattsson, Niklas, et al.
Publicado: (2016)

Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease
por: Hansson, Oskar, et al.
Publicado: (2020)

Plasma proenkephalin A 119–159 on intensive care unit admission is a predictor of organ failure and 30-day mortality
por: Frigyesi, Attila, et al.
Publicado: (2021)

Neurofilament light and tau as blood biomarkers for sports-related concussion
por: Shahim, Pashtun, et al.
Publicado: (2018)

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury
por: Shahim, Pashtun, et al.
Publicado: (2016)

A structured approach to neurologic prognostication in clinical cardiac arrest trials
por: Cronberg, Tobias, et al.
Publicado: (2013)

GFAp and tau protein as predictors of neurological outcome after out-of-hospital cardiac arrest: A post hoc analysis of the COMACARE trial
por: Humaloja, Jaana, et al.
Publicado: (2022)

Serum proteome profiles in patients treated with targeted temperature management after out-of-hospital cardiac arrest
por: Lileikyte, Gabriele, et al.
Publicado: (2023)

Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2021)

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2020)

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
por: Cicognola, Claudia, et al.
Publicado: (2021)

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease
por: Mattsson, Niklas, et al.
Publicado: (2010)

Cerebrospinal Fluid Analysis Should Be Considered in Patients with Cognitive Problems
por: Zetterberg, Henrik, et al.
Publicado: (2010)

Blood neurofilament light in remote settings: Alternative protocols to support sample collection in challenging pre‐analytical conditions
por: Simrén, Joel, et al.
Publicado: (2021)

Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease
por: Zetterberg, Henrik, et al.
Publicado: (2010)

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
por: Skillbäck, Tobias, et al.
Publicado: (2013)

Artificial neural networks improve early outcome prediction and risk classification in out-of-hospital cardiac arrest patients admitted to intensive care
por: Johnsson, Jesper, et al.
Publicado: (2020)

Carbon dioxide flooding to reduce postoperative neurological injury following surgery for acute type A aortic dissection: a prospective, randomised, blinded, controlled clinical trial, CARTA study protocol - objectives and design
por: Ede, Jacob, et al.
Publicado: (2023)

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
por: Cullen, Nicholas C., et al.
Publicado: (2020)

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
por: Bergman, Joakim, et al.
Publicado: (2016)

Serial soluble neurofilament heavy chain in plasma as a marker of brain injury after cardiac arrest
por: Rundgren, Malin, et al.
Publicado: (2012)

Associations between partial pressure of oxygen and neurological outcome in out-of-hospital cardiac arrest patients: an explorative analysis of a randomized trial
por: Ebner, Florian, et al.
Publicado: (2019)

Serum Neurofilament Light Chain as a Marker of Progression in Parkinson’s Disease: Long-Term Observation and Implications of Clinical Subtypes
por: Ygland Rödström, Emil, et al.
Publicado: (2022)

Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators
por: Moseby-Knappe, Marion, et al.
Publicado: (2022)

Biomarkers for tau pathology
por: Schöll, Michael, et al.
Publicado: (2019)

Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2021)

Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads
por: Salvadó, Gemma, et al.
Publicado: (2023)

Predicting survival and neurological outcome in out-of-hospital cardiac arrest using machine learning: the SCARS model
por: Hessulf, Fredrik, et al.
Publicado: (2023)

Carbon dioxide dynamics in relation to neurological outcome in resuscitated out-of-hospital cardiac arrest patients: an exploratory Target Temperature Management Trial substudy
por: Ebner, Florian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_45c2ers8qlegm4qt12s7pmn197